This Case Study describes a patient with breast cancer who was treated with capecitabine and experienced a severe adverse event when treated with brivudin for a herpes infection. The authors discuss drug–drug interactions and management of the associated toxic effects.
- José M. Baena-Cañada
- María J. Martínez
- Pedro Muriel-Cueto